AstraZeneca Canada Inc. manufactures drugs in the treatment of a•allergic rhinitis •asthma b•bronchitis •bronchospasm associated with COPD c•chronic bronchitis (COPD) •COPD e•emphysema (COPD) f•flu h•hay fever i•influenza n•nasal polyps •non-small cell lung cancer p•perennial rhinitis r•rhinitis •runny nose s•seasonal rhinitis

Drugs manufactured by AstraZeneca Canada Inc. include

B•Breztri™ Aerosphere® inhaler •Bricanyl® Turbuhaler® inhaler D•Daxas® tablets •Duaklir® Genuair® inhaler F•Fasenra® injection •FluMist® vaccine I•Imfinzi® injection •Iressa® tablets O•Oxeze® Turbuhaler® inhaler P•Pulmicort® Nebuamp® inhalation suspension •Pulmicort® Turbuhaler® inhaler R•Rhinocort® Aqua nasal spray S•Symbicort® Turbuhaler® inhaler T•Tagrisso® tablets •Tezspire™ •Tudorza® Genuair®